Dosage regime
Grant
US12576050B2
Kind: B2
Mar 17, 2026
Assignee
NOVABIOTICS LIMITED
Inventors
Deborah O'Neil
Abstract
The present disclosure relates to use of cysteamine, formulations comprising cysteamine and pharmaceutically acceptable salts of cysteamine in the treatment of cystic fibrosis and conditions associated with cystic fibrosis.
CPC Classifications
A61K 31/145
A61P 11/00
A61P 11/12
Filing Date
2019-10-17
Application No.
17286282
Claims
11